UGT1A9 and neoplasm: After FDR p-value correction employing p-values of the different gene variants selected, only the TA variant in UGT1A9 rs6714486 of the recipient (Table 4) was significantly (p = 0.032) related to lower tumor probability (HR: 0.13).